P. Schoenfeld Asset Management (PSAM)’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-497,500
Closed -$72.8M 44
2019
Q1
$72.8M Buy
+497,500
New +$72.1M 5.72% 7
2018
Q3
Sell
-602,000
Closed -$100K 46
2018
Q2
$100K Buy
602,000
+352,000
+141% +$56.5M 5.67% 4
2018
Q1
$42.1M Buy
+250,000
New +$41.9M 2.47% 14
2017
Q2
Sell
-150,000
Closed -$35.8M 51
2017
Q1
$35.8M Sell
150,000
-43,100
-22% -$10M 2.81% 13
2016
Q4
$40.6M Buy
193,100
+102,400
+113% +$21.2M 4.28% 5
2016
Q3
$20.9M Buy
90,700
+40,000
+79% +$9.77M 1.6% 24
2016
Q2
$11.7M Buy
50,700
+2,400
+5% +$553K 0.75% 30
2016
Q1
$12.9M Sell
48,300
-93,100
-66% -$26.7M 0.91% 31
2015
Q4
$44.2M Buy
+141,400
New +$42.1M 2.71% 15

Other funds holding AGN

P. Schoenfeld Asset Management (PSAM)'s AGN Position: Q2 2020 in Review

P. Schoenfeld Asset Management (PSAM) sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 35,000 shares — an estimated $6.2M sold.

P. Schoenfeld Asset Management (PSAM) first reported a position in AGN in Q1 2016 and held it in 9 quarters. The position peaked at $95M in Q3 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • P. Schoenfeld Asset Management (PSAM) reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • P. Schoenfeld Asset Management (PSAM) sold 35,000 Allergan plc shares in Q2 2020, an estimated $6.2M.
  • P. Schoenfeld Asset Management (PSAM) first reported a position in Allergan plc in Q1 2016 and held it in 9 quarters.
  • P. Schoenfeld Asset Management (PSAM)'s Allergan plc position peaked at $95M in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q2 2020, filed 14 Aug 2020.